Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Avalo Therapeutics Inc (AVTX)

Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avalo Therapeutics Inc 1500 Liberty Ridge Drive Suite 321 Wayne PA 19087 USA

www.avalotx.com Employees: 23 P: 410-522-8707

Sector:

Medical

Description:

Avalo Therapeutics Inc. is a clinical-stage precision medicine company which discovers, develops and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology and rare genetic diseases. Avalo Therapeutics Inc., formerly known as Cerecor, is based in WAYNE, Pa.

Key Statistics

Overview:

Market Capitalization, $K 43,312
Enterprise Value, $K -91,258
Shares Outstanding, K 10,828
Annual Sales, $ 440 K
Annual Net Income, $ -35,130 K
Last Quarter Sales, $ 190 K
Last Quarter Net Income, $ -35,340 K
EBIT, $ -68,520 K
EBITDA, $ -68,350 K
60-Month Beta 0.87
% of Insider Shareholders 0.25%
% of Institutional Shareholders 87.06%
Float, K 10,801
% Float 99.75%
Short Volume Ratio 0.13

Growth:

1-Year Return -58.29%
3-Year Return -99.57%
5-Year Return -99.96%
5-Year Revenue Growth -93.48%
5-Year Earnings Growth 97.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.25 on 05/12/25
Next Earnings Date N/A
Earnings Per Share ttm -22.88
EPS Growth vs. Prev Year 79.10%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-240 on 12/29/23

AVTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 111.00%
Return-on-Assets % 58.88%
Profit Margin % -7,984.09%
Debt/Equity 0.00
Price/Sales 96.00
Price/Cash Flow N/A
Price/Book 0.34
Book Value/Share 12.80
Interest Coverage -1.03
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar